retatrutide type 2 diabetes phase 2 results The next installment of the triple agonist is here with more top-line 3 results. TRANSCEND-T2D-1: Retatrutide in adults with obesity and diabetes. ๐ Lowered A1C of 1.7%โ2.0% across The numbers from Lilly's Phase
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Jul 31 - Aug 5



















